WuXi AppTec plans China-HK share sale
Chinese pharmaceutical company WuXi AppTec Co is planning to raise primary equity through an issue of H-shares and its Shanghai-listed A-shares.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: